58 Epigenetic editing as a promising strategy to enhance efficacy and genomic integrity of CAR T cell therapy

• Yaqin Li,
• Shutan Jiang,
• Hongye Wang,
• Shaoshuai Mao,
• Leilei Wu,
• Xiaodong Huang,
• Bob Zhang

Affiliations

Yaqin Li

Epigenic Therapeutics, Shanghai, China

Shutan Jiang

Epigenic Therapeutics, Shanghai, China

Hongye Wang

Epigenic Therapeutics, Shanghai, China

Shaoshuai Mao

Epigenic Therapeutics, Shanghai, China

Leilei Wu

Epigenic Therapeutics, Shanghai, China

Xiaodong Huang

Epigenic Therapeutics, Shanghai, China

Bob Zhang

Epigenic Therapeutics, Shanghai, China